Patents by Inventor Haiyan Hu
Haiyan Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11301163Abstract: A NOF-based read control method, apparatus, and system belong to the field of networked storage. The method includes: receiving, by a NOF engine by using a communication link, a read request sent by a host; sending at least one read command to an NVMe hard disk based on the read request; and when congestion occurs on the communication link, generating a congestion flag corresponding to the communication link, and sending the congestion flag to the NVMe hard disk, where the congestion flag is used to instruct the NVMe hard disk to suspend processing of the read command corresponding to the communication link.Type: GrantFiled: June 25, 2020Date of Patent: April 12, 2022Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Shengguang Zhang, Haiyan Hu, Xinqian Zheng
-
Patent number: 10835539Abstract: Use of 5?-androstane-3?,5,6?-triol and analogs thereof in the preparation of a drug for the prophylaxis or treatment of an altitude sickness caused by hypobaric hypoxia is provided, so as to provide a new drug for the prophylaxis or treatment of an altitude sickness. Researches revealed that 5?-androstane-3?,5,6?-triol treatment can effectively reduce vasogenic edema of brain tissue of Macaca fascicularis caused by hypobaric hypoxia, reduce the increased cerebral water content, and protect from neuronal vacuolar degeneration caused by hypobaric hypoxia, therefore it can improve neurological dysfunctions caused by hypobaric hypoxia and is useful in prophylaxis or treatment of an altitude sickness.Type: GrantFiled: March 25, 2019Date of Patent: November 17, 2020Assignee: Guangzhou Cellprotek Pharmaceutical Co., Ltd.Inventors: Wei Yin, Jiesi Chen, Guangmei Yan, Bingzheng Lu, Wenbo Zhu, Haiyan Hu, Pengxin Qiu, Yijun Huang, Jingxia Zhang
-
Publication number: 20200326879Abstract: A NOF-based read control method, apparatus, and system belong to the field of networked storage. The method includes: receiving, by a NOF engine by using a communication link, a read request sent by a host; sending at least one read command to an NVMe hard disk based on the read request; and when congestion occurs on the communication link, generating a congestion flag corresponding to the communication link, and sending the congestion flag to the NVMe hard disk, where the congestion flag is used to instruct the NVMe hard disk to suspend processing of the read command corresponding to the communication link.Type: ApplicationFiled: June 25, 2020Publication date: October 15, 2020Inventors: Shengguang Zhang, Haiyan Hu, Xinqian Zheng
-
Patent number: 10534552Abstract: An SR-IOV-supported storage resource access method is disclosed, the method includes: consolidating a storage medium as a unified storage resource, and dividing the unified storage resource into multiple storage sub-resources; allocating the storage sub-resources to at least one of a PF or a VF according to a preset allocation rule, and maintaining a resource allocation table including a mapping relationship between the storage sub-resources and at least one of PF or VF; receiving a host command sent by a virtual machine to a destination VF or by a virtual machine monitor to a destination PF; and searching the resource allocation table according to destination VF or destination PF, and performing, on a storage sub-resource corresponding to destination PF or destination VF and according to the mapping relationship between the storage sub-resources and the PF or the VF in the resource allocation table, an operation corresponding to the host command.Type: GrantFiled: April 28, 2017Date of Patent: January 14, 2020Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Haiyan Hu, Shaofeng Shen, Miao Tang
-
Publication number: 20190262358Abstract: Use of 5?-androstane-3?,5,6?-triol and analogs thereof in the preparation of a drug for the prophylaxis or treatment of an altitude sickness caused by hypobaric hypoxia is provided, so as to provide a new drug for the prophylaxis or treatment of an altitude sickness. Researches revealed that 5?-androstane-3?,5,6?-triol treatment can effectively reduce vasogenic edema of brain tissue of Macaca fascicularis caused by hypobaric hypoxia, reduce the increased cerebral water content, and protect from neuronal vacuolar degeneration caused by hypobaric hypoxia, therefore it can improve neurological dysfunctions caused by hypobaric hypoxia and is useful in prophylaxis or treatment of an altitude sickness.Type: ApplicationFiled: March 25, 2019Publication date: August 29, 2019Inventors: Wei Yin, Jiesi Chen, Guangmei Yan, Bingzheng Lu, Wenbo Zhu, Haiyan Hu, Pengxin Qiu, Yijun Huang, Jingxia Zhang
-
Patent number: 10357500Abstract: Use of 5?-androstane-3?,5,6?-triol and analogs thereof in the preparation of a drug for the prophylaxis or treatment of an altitude sickness caused by hypobaric hypoxia is provided, so as to provide a new drug for the prophylaxis or treatment of an altitude sickness. Researches revealed that 5?-androstane-3?,5,6?-triol treatment can effectively reduce vasogenic edema of brain tissue of Macaca fascicularis caused by hypobaric hypoxia, reduce the increased cerebral water content, and protect from neuronal vacuolar degeneration caused by hypobaric hypoxia, therefore it can improve neurological dysfunctions caused by hypobaric hypoxia and is useful in prophylaxis or treatment of an altitude sickness.Type: GrantFiled: April 14, 2015Date of Patent: July 23, 2019Assignee: Guangzhou Cellprotek Pharmaceutical Co., Ltd.Inventors: Wei Yin, Jiesi Chen, Guangmei Yan, Bingzheng Lu, Wenbo Zhu, Haiyan Hu, Pengxin Qiu, Yijun Huang, Jingxia Zhang
-
Publication number: 20170235510Abstract: An SR-IOV-supported storage resource access method is disclosed, the method includes: consolidating a storage medium as a unified storage resource, and dividing the unified storage resource into multiple storage sub-resources; allocating the storage sub-resources to at least one of a PF or a VF according to a preset allocation rule, and maintaining a resource allocation table including a mapping relationship between the storage sub-resources and at least one of PF or VF; receiving a host command sent by a virtual machine to a destination VF or by a virtual machine monitor to a destination PF; and searching the resource allocation table according to destination VF or destination PF, and performing, on a storage sub-resource corresponding to destination PF or destination VF and according to the mapping relationship between the storage sub-resources and the PF or the VF in the resource allocation table, an operation corresponding to the host command.Type: ApplicationFiled: April 28, 2017Publication date: August 17, 2017Applicant: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Haiyan HU, Shaofeng SHEN, Miao TANG
-
Publication number: 20170042909Abstract: Use of 5?-androstane-3?,5,6?-triol and analogs thereof in the preparation of a drug for the prophylaxis or treatment of an altitude sickness caused by hypobaric hypoxia is provided, so as to provide a new drug for the prophylaxis or treatment of an altitude sickness. Researches revealed that 5?-androstane-3?,5,6?-triol treatment can effectively reduce vasogenic edema of brain tissue of Macaca fascicularis caused by hypobaric hypoxia, reduce the increased cerebral water content, and protect from neuronal vacuolar degeneration caused by hypobaric hypoxia, therefore it can improve neurological dysfunctions caused by hypobaric hypoxia and is useful in prophylaxis or treatment of an altitude sickness.Type: ApplicationFiled: April 14, 2015Publication date: February 16, 2017Inventors: Wei Yin, Jiesi Chen, Guangmei Yan, Bingzheng Lu, Wenbo Zhu, Haiyan Hu, Pengxin Qiu, Yijun Huang, Jingxia Zhang
-
Patent number: 9320743Abstract: Disclosed is the use of 5?-androstane-3?,5,6?-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord ischemia or hypoxia and has no obvious toxic reaction within effective dose thereof.Type: GrantFiled: July 15, 2014Date of Patent: April 26, 2016Assignee: GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.Inventors: Guangmei Yan, Haiyan Hu, Tiandong Leng, Hanfei Sang, Jingxia Zhang, Pengxin Qiu, Shujia Zhou, Jiesi Chen, Xiuhua You
-
Publication number: 20160051685Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection. Drying the filtrate yields a solid for injection.Type: ApplicationFiled: August 28, 2015Publication date: February 25, 2016Applicant: Guangzhou Cellprotek Pharmaceutical LTD.Inventors: Guangmei Yan, Haiyan HU, Jingxia ZHANG, Pengxin QIU, Ling LI, Ning TIAN
-
Patent number: 9265837Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection. Drying the filtrate yields a solid for injection.Type: GrantFiled: August 28, 2015Date of Patent: February 23, 2016Assignee: Guangzhou Cellprotek Pharmaceuticals Ltd.Inventors: Guangmei Yan, Haiyan Hu, Jingxia Zhang, Pengxin Qiu, Ling Li, Ning Tian
-
Publication number: 20140329790Abstract: Disclosed is the use of 5?-androstane-3?,5,6?-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord ischemia or hypoxia and has no obvious toxic reaction within effective dose thereof.Type: ApplicationFiled: July 15, 2014Publication date: November 6, 2014Applicant: GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.Inventors: Guangmei YAN, Haiyan HU, Tiandong LENG, Hanfei SANG, Jingxia ZHANG, Pengxin QIU, Shujia ZHOU, Jiesi CHEN, Xiuhua YOU
-
Patent number: 8809309Abstract: Disclosed is the use of 5?-androstane(alkyl)-3?,5,6?-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord ischemia or hypoxia and has no obvious toxic reaction within effective dose thereof.Type: GrantFiled: July 8, 2011Date of Patent: August 19, 2014Assignee: Guangzhou Cellprotek Pharmaceutical Ltd.Inventors: Guangmei Yan, Haiyan Hu, Tiandong Leng, Hanfei Sang, Jingxia Zhang, Pengxin Qiu, Shujia Zhou, Jiesi Chen, Xiuhua You
-
Publication number: 20130157993Abstract: Disclosed is the use of 5?-androstane(alkyl)-3?,5,6?-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord isehemia or hypoxia and has no obvious toxic reaction within effective dose thereof.Type: ApplicationFiled: July 8, 2011Publication date: June 20, 2013Inventors: Guangmei Yan, Haiyan Hu, Tiandong Leng, Hanfei Sang, Jingxia Zhang, Pengxin Qiu, Shujia Zhou, Jiesi Chen, Xiuhua You
-
Patent number: D901421Type: GrantFiled: March 30, 2019Date of Patent: November 10, 2020Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Haiyan Hu, Meng Li, Ze Yuan
-
Patent number: D914024Type: GrantFiled: September 21, 2018Date of Patent: March 23, 2021Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Joon Suh Kim, Ting Xu, Zhenqi Tang, Haibo Luo, Ying Zhao, Haiyan Hu, Meng Li, Ze Yuan
-
Patent number: D1004977Type: GrantFiled: July 10, 2023Date of Patent: November 21, 2023Inventor: Haiyan Hu